Comparison of Alectinib/Crizotinib Data in First-Line Therapy in Patients with Anaplastic Lymphomakinase- Positive Nonsmall Cell Lung Carcinoma with Poor Prognostic Features for Alectinib için istatistikler

Toplam ziyaret

views
Comparison of Alectinib/Crizotinib Data in First-Line Therapy in Patients with Anaplastic Lymphomakinase- Positive Nonsmall Cell Lung Carcinoma with Poor Prognostic Features for Alectinib 1

Aylık toplam ziyaret

views
Ocak 2025 0
Şubat 2025 0
Mart 2025 0
Nisan 2025 0
Mayıs 2025 0
Haziran 2025 0
Temmuz 2025 0

Dosya Ziyaretleri

views
1502.pdf 11